Evaxion Biotech As Stock Gross Profit

EVAX Stock

USD 1.66 0.09 5.73%

Evaxion Biotech AS fundamentals help investors to digest information that contributes to Evaxion Biotech's financial success or failures. It also enables traders to predict the movement of Evaxion Stock. The fundamental analysis module provides a way to measure Evaxion Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evaxion Biotech stock.

	Last Reported	Projected for Next Year
Gross Profit	72.9 K	76.5 K
Gross Profit Margin	0.90	0.80

Gross Profit is likely to rise to about 76.5 K in 2024, whereas Gross Profit Margin is likely to drop 0.80 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Evaxion Biotech AS Company Gross Profit Analysis

Evaxion Biotech's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Current Evaxion Biotech Gross Profit

76.5K

Most of Evaxion Biotech's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evaxion Biotech AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Evaxion Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Evaxion Biotech is extremely important. It helps to project a fair market value of Evaxion Stock properly, considering its historical fundamentals such as Gross Profit. Since Evaxion Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Evaxion Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Evaxion Biotech's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Net Tangible Assets	Short Long Term Debt	Capital Stock	Property Plant Equipment	Intangible Assets	Long Term Debt	Current Deferred Revenue	Short Term Investments
Total Assets		0.43	-0.15	0.05	0.12	0.25	-0.09	0.16	0.29	0.17	0.06	0.0	0.01	-0.04	0.01	-0.04	-0.08	-0.41	-0.17	-0.17
Total Stockholder Equity	0.43		0.65	0.48	-0.46	0.35	-0.47	-0.77	-0.7	-0.72	0.01	-0.48	-0.58	0.47	-0.47	-0.66	0.31	-0.49	-0.03	-0.03
Net Debt	-0.15	0.65		0.04	-0.42	0.03	0.03	-0.93	-0.81	-0.97	0.12	-0.12	-0.33	0.44	-0.11	-0.23	-0.12	0.17	-0.39	-0.39
Retained Earnings	0.05	0.48	0.04		-0.73	0.63	-0.94	-0.31	-0.51	-0.23	0.07	-0.92	-0.94	0.79	-0.94	-0.95	0.94	-0.91	0.78	0.78
Accounts Payable	0.12	-0.46	-0.42	-0.73		-0.4	0.66	0.55	0.61	0.51	-0.12	0.73	0.81	-0.88	0.73	0.68	-0.55	0.52	-0.36	-0.36
Net Receivables	0.25	0.35	0.03	0.63	-0.4		-0.77	-0.25	-0.36	-0.07	-0.49	-0.54	-0.65	0.64	-0.55	-0.54	0.51	-0.64	0.41	0.41
Total Liab	-0.09	-0.47	0.03	-0.94	0.66	-0.77		0.29	0.49	0.13	0.25	0.84	0.86	-0.7	0.85	0.89	-0.89	0.87	-0.75	-0.75
Net Invested Capital	0.16	-0.77	-0.93	-0.31	0.55	-0.25	0.29		0.95	0.96	0.07	0.36	0.54	-0.56	0.35	0.5	-0.17	0.08	0.14	0.14
Total Current Assets	0.29	-0.7	-0.81	-0.51	0.61	-0.36	0.49	0.95		0.89	0.07	0.5	0.71	-0.67	0.51	0.67	-0.44	0.23	-0.17	-0.17
Net Working Capital	0.17	-0.72	-0.97	-0.23	0.51	-0.07	0.13	0.96	0.89		-0.19	0.3	0.49	-0.53	0.29	0.43	-0.09	0.01	0.2	0.2
Short Term Debt	0.06	0.01	0.12	0.07	-0.12	-0.49	0.25	0.07	0.07	-0.19		-0.09	-0.13	0.16	-0.09	-0.08	0.07	-0.06	0.05	0.05
Common Stock	0.0	-0.48	-0.12	-0.92	0.73	-0.54	0.84	0.36	0.5	0.3	-0.09		0.87	-0.74	1.0	0.89	-0.79	0.85	-0.56	-0.56
Net Tangible Assets	0.01	-0.58	-0.33	-0.94	0.81	-0.65	0.86	0.54	0.71	0.49	-0.13	0.87		-0.93	0.89	0.93	-0.85	0.78	-0.64	-0.64
Short Long Term Debt	-0.04	0.47	0.44	0.79	-0.88	0.64	-0.7	-0.56	-0.67	-0.53	0.16	-0.74	-0.93		-0.75	-0.74	0.64	-0.6	0.45	0.45
Capital Stock	0.01	-0.47	-0.11	-0.94	0.73	-0.55	0.85	0.35	0.51	0.29	-0.09	1.0	0.89	-0.75		0.9	-0.82	0.86	-0.6	-0.6
Property Plant Equipment	-0.04	-0.66	-0.23	-0.95	0.68	-0.54	0.89	0.5	0.67	0.43	-0.08	0.89	0.93	-0.74	0.9		-0.91	0.84	-0.69	-0.69
Intangible Assets	-0.08	0.31	-0.12	0.94	-0.55	0.51	-0.89	-0.17	-0.44	-0.09	0.07	-0.79	-0.85	0.64	-0.82	-0.91		-0.82	0.93	0.93
Long Term Debt	-0.41	-0.49	0.17	-0.91	0.52	-0.64	0.87	0.08	0.23	0.01	-0.06	0.85	0.78	-0.6	0.86	0.84	-0.82		-0.66	-0.66
Current Deferred Revenue	-0.17	-0.03	-0.39	0.78	-0.36	0.41	-0.75	0.14	-0.17	0.2	0.05	-0.56	-0.64	0.45	-0.6	-0.69	0.93	-0.66		1.0
Short Term Investments	-0.17	-0.03	-0.39	0.78	-0.36	0.41	-0.75	0.14	-0.17	0.2	0.05	-0.56	-0.64	0.45	-0.6	-0.69	0.93	-0.66	1.0

Click cells to compare fundamentals

Evaxion Gross Profit Historical Pattern

Today, most investors in Evaxion Biotech Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Evaxion Biotech's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's gross profit growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Evaxion Biotech gross profit as a starting point in their analysis.

Evaxion Biotech Gross Profit

Timeline

Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Competition

Predict Evaxion Biotech

Gross Profit Over Time

Evaxion Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evaxion Biotech's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evaxion Biotech could also be used in its relative valuation, which is a method of valuing Evaxion Biotech by comparing valuation metrics of similar companies.

Evaxion Biotech is currently under evaluation in gross profit category among its peers.

Evaxion Fundamentals

	Return On Equity	-8.03
	Return On Asset	-0.69
	Operating Margin	(0.57) %
	Current Valuation	12.23 M
	Shares Outstanding	5.58 M
	Shares Owned By Insiders	25.20 %
	Shares Owned By Institutions	8.16 %
	Number Of Shares Shorted	36.02 K
	Price To Book	131.59 X
	Price To Sales	2.96 X
	Revenue	73 K
	EBITDA	(21.4 M)
	Net Income	(22.12 M)
	Cash And Equivalents	25.25 M
	Cash Per Share	1.06 X
	Total Debt	10.87 M
	Debt To Equity	0.48 %
	Current Ratio	6.47 X
	Book Value Per Share	0.01 X
	Cash Flow From Operations	(17.69 M)
	Short Ratio	2.07 X
	Earnings Per Share	(2.80) X
	Target Price	10.85
	Number Of Employees	49
	Beta	-0.23
	Market Capitalization	13.28 M
	Total Asset	12.89 M
	Retained Earnings	(107.97 M)
	Working Capital	1.27 M
	Net Asset	12.89 M

About Evaxion Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Evaxion Biotech AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evaxion Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evaxion Biotech AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC